Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT

Livio Pagano, Alessio Maria Edoardo Maraglino, Luana Fianchi, Marianna Criscuolo, Elena Rossi, Tommaso Za, Patrizia Chiusolo, Matteo Bonanni, Giulia Dragonetti, Andrea Bacigalupo, Simona Sica, Valerio De Stefano

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)207-209
Number of pages3
JournalAnnals of Hematology
Issue number1
Publication statusPublished - Jan 2020


  • Aged
  • Antineoplastic Combined Chemotherapy Protocols/administration & dosage
  • Autografts
  • Bortezomib/administration & dosage
  • Cyclophosphamide/administration & dosage
  • Dexamethasone/administration & dosage
  • Disease-Free Survival
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Plasma Cell/mortality
  • Male
  • Middle Aged
  • Survival Rate

Cite this